APO Research
Talk to an analyst

APO RESEARCH · REPORT

Linagliptin Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Linagliptin Tablets Industry Research Report 2026

27 December 2025148 pages

Choose your research edition.

Industry ResearchLinagliptin Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Linagliptin Tablets Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Linagliptin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Linagliptin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Linagliptin Tablets Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Linagliptin Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Linagliptin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Linagliptin Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Linagliptin Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Linagliptin Tablets include Alkem, Boehringer Ingelheim, Cipla, Eli Lilly, Kyongbo Pharmaceutical, Lupin, Mankind Pharma, Myungmoon Pharm and Natco Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Linagliptin Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Linagliptin Tablets Market by Company

Alkem

Boehringer Ingelheim

Cipla

Eli Lilly

Kyongbo Pharmaceutical

Lupin

Mankind Pharma

Myungmoon Pharm

Natco Pharma

Torrent Pharmaceuticals

Withus Pharmaceutical

Zydus

Chengdu Brilliant Pharmaceutical

HEC Pharm

Hangzhou Minsheng Pharmaceutical

Kelun Pharmaceutical

Qilu Pharmaceutical

CSPC Ouyi Pharmaceutical

Yangtze River Pharmaceutical

Zhejiang Huahai Pharmaceutical

Linagliptin Tablets Segment by Type

Original Drug

Generic Drug

Linagliptin Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Linagliptin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Linagliptin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Linagliptin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Linagliptin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Linagliptin Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Linagliptin Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Linagliptin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Linagliptin Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Linagliptin Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Linagliptin Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Linagliptin Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Linagliptin Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Linagliptin Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Linagliptin Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Linagliptin Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Linagliptin Tablets, Product Type & Application Table 14. Global Linagliptin Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Linagliptin Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Alkem Company Information Table 19. Alkem Business Overview Table 20. Alkem Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Alkem Linagliptin Tablets Product Portfolio Table 22. Alkem Recent Developments Table 23. Boehringer Ingelheim Company Information Table 24. Boehringer Ingelheim Business Overview Table 25. Boehringer Ingelheim Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Boehringer Ingelheim Linagliptin Tablets Product Portfolio Table 27. Boehringer Ingelheim Recent Developments Table 28. Cipla Company Information Table 29. Cipla Business Overview Table 30. Cipla Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Cipla Linagliptin Tablets Product Portfolio Table 32. Cipla Recent Developments Table 33. Eli Lilly Company Information Table 34. Eli Lilly Business Overview Table 35. Eli Lilly Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Eli Lilly Linagliptin Tablets Product Portfolio Table 37. Eli Lilly Recent Developments Table 38. Kyongbo Pharmaceutical Company Information Table 39. Kyongbo Pharmaceutical Business Overview Table 40. Kyongbo Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Kyongbo Pharmaceutical Linagliptin Tablets Product Portfolio Table 42. Kyongbo Pharmaceutical Recent Developments Table 43. Lupin Company Information Table 44. Lupin Business Overview Table 45. Lupin Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Lupin Linagliptin Tablets Product Portfolio Table 47. Lupin Recent Developments Table 48. Mankind Pharma Company Information Table 49. Mankind Pharma Business Overview Table 50. Mankind Pharma Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mankind Pharma Linagliptin Tablets Product Portfolio Table 52. Mankind Pharma Recent Developments Table 53. Myungmoon Pharm Company Information Table 54. Myungmoon Pharm Business Overview Table 55. Myungmoon Pharm Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Myungmoon Pharm Linagliptin Tablets Product Portfolio Table 57. Myungmoon Pharm Recent Developments Table 58. Natco Pharma Company Information Table 59. Natco Pharma Business Overview Table 60. Natco Pharma Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Natco Pharma Linagliptin Tablets Product Portfolio Table 62. Natco Pharma Recent Developments Table 63. Torrent Pharmaceuticals Company Information Table 64. Torrent Pharmaceuticals Business Overview Table 65. Torrent Pharmaceuticals Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Torrent Pharmaceuticals Linagliptin Tablets Product Portfolio Table 67. Torrent Pharmaceuticals Recent Developments Table 68. Withus Pharmaceutical Company Information Table 69. Withus Pharmaceutical Business Overview Table 70. Withus Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Withus Pharmaceutical Linagliptin Tablets Product Portfolio Table 72. Withus Pharmaceutical Recent Developments Table 73. Zydus Company Information Table 74. Zydus Business Overview Table 75. Zydus Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zydus Linagliptin Tablets Product Portfolio Table 77. Zydus Recent Developments Table 78. Chengdu Brilliant Pharmaceutical Company Information Table 79. Chengdu Brilliant Pharmaceutical Business Overview Table 80. Chengdu Brilliant Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chengdu Brilliant Pharmaceutical Linagliptin Tablets Product Portfolio Table 82. Chengdu Brilliant Pharmaceutical Recent Developments Table 83. HEC Pharm Company Information Table 84. HEC Pharm Business Overview Table 85. HEC Pharm Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. HEC Pharm Linagliptin Tablets Product Portfolio Table 87. HEC Pharm Recent Developments Table 88. Hangzhou Minsheng Pharmaceutical Company Information Table 89. Hangzhou Minsheng Pharmaceutical Business Overview Table 90. Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Product Portfolio Table 92. Hangzhou Minsheng Pharmaceutical Recent Developments Table 93. Kelun Pharmaceutical Company Information Table 94. Kelun Pharmaceutical Business Overview Table 95. Kelun Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Kelun Pharmaceutical Linagliptin Tablets Product Portfolio Table 97. Kelun Pharmaceutical Recent Developments Table 98. Qilu Pharmaceutical Company Information Table 99. Qilu Pharmaceutical Business Overview Table 100. Qilu Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Qilu Pharmaceutical Linagliptin Tablets Product Portfolio Table 102. Qilu Pharmaceutical Recent Developments Table 103. CSPC Ouyi Pharmaceutical Company Information Table 104. CSPC Ouyi Pharmaceutical Business Overview Table 105. CSPC Ouyi Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CSPC Ouyi Pharmaceutical Linagliptin Tablets Product Portfolio Table 107. CSPC Ouyi Pharmaceutical Recent Developments Table 108. Yangtze River Pharmaceutical Company Information Table 109. Yangtze River Pharmaceutical Business Overview Table 110. Yangtze River Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Yangtze River Pharmaceutical Linagliptin Tablets Product Portfolio Table 112. Yangtze River Pharmaceutical Recent Developments Table 113. Zhejiang Huahai Pharmaceutical Company Information Table 114. Zhejiang Huahai Pharmaceutical Business Overview Table 115. Zhejiang Huahai Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Zhejiang Huahai Pharmaceutical Linagliptin Tablets Product Portfolio Table 117. Zhejiang Huahai Pharmaceutical Recent Developments Table 118. Global Linagliptin Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Linagliptin Tablets Sales by Region (2021-2026) & (K Units) Table 120. Global Linagliptin Tablets Sales Market Share by Region (2021-2026) Table 121. Global Linagliptin Tablets Sales by Region (2027-2032) & (K Units) Table 122. Global Linagliptin Tablets Sales Market Share by Region (2027-2032) Table 123. Global Linagliptin Tablets Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Linagliptin Tablets Revenue Market Share by Region (2021-2026) Table 125. Global Linagliptin Tablets Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Linagliptin Tablets Revenue Market Share by Region (2027-2032) Table 127. North America Linagliptin Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Linagliptin Tablets Sales by Country (2021-2026) & (K Units) Table 129. North America Linagliptin Tablets Sales by Country (2027-2032) & (K Units) Table 130. North America Linagliptin Tablets Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Linagliptin Tablets Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Linagliptin Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Linagliptin Tablets Sales by Country (2021-2026) & (K Units) Table 134. Europe Linagliptin Tablets Sales by Country (2027-2032) & (K Units) Table 135. Europe Linagliptin Tablets Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Linagliptin Tablets Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Linagliptin Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Linagliptin Tablets Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Linagliptin Tablets Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Linagliptin Tablets Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Linagliptin Tablets Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Linagliptin Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Linagliptin Tablets Sales by Country (2021-2026) & (K Units) Table 144. South America Linagliptin Tablets Sales by Country (2027-2032) & (K Units) Table 145. South America Linagliptin Tablets Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Linagliptin Tablets Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Linagliptin Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Linagliptin Tablets Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Linagliptin Tablets Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Linagliptin Tablets Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Linagliptin Tablets Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Linagliptin Tablets Sales by Type (2021-2026) & (K Units) Table 153. Global Linagliptin Tablets Sales by Type (2027-2032) & (K Units) Table 154. Global Linagliptin Tablets Sales Market Share by Type (2021-2026) Table 155. Global Linagliptin Tablets Sales Market Share by Type (2027-2032) Table 156. Global Linagliptin Tablets Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Linagliptin Tablets Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Linagliptin Tablets Revenue Market Share by Type (2021-2026) Table 159. Global Linagliptin Tablets Revenue Market Share by Type (2027-2032) Table 160. Global Linagliptin Tablets Price by Type (2021-2026) & (US$/Unit) Table 161. Global Linagliptin Tablets Price by Type (2027-2032) & (US$/Unit) Table 162. Global Linagliptin Tablets Sales by Application (2021-2026) & (K Units) Table 163. Global Linagliptin Tablets Sales by Application (2027-2032) & (K Units) Table 164. Global Linagliptin Tablets Sales Market Share by Application (2021-2026) Table 165. Global Linagliptin Tablets Sales Market Share by Application (2027-2032) Table 166. Global Linagliptin Tablets Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Linagliptin Tablets Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Linagliptin Tablets Revenue Market Share by Application (2021-2026) Table 169. Global Linagliptin Tablets Revenue Market Share by Application (2027-2032) Table 170. Global Linagliptin Tablets Price by Application (2021-2026) & (US$/Unit) Table 171. Global Linagliptin Tablets Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Linagliptin Tablets Distributors List Table 175. Linagliptin Tablets Customers List Table 176. Linagliptin Tablets Industry Trends Table 177. Linagliptin Tablets Industry Drivers Table 178. Linagliptin Tablets Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Linagliptin Tablets Product Image Figure 5. Global Linagliptin Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Linagliptin Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Linagliptin Tablets Sales (2021-2032) & (K Units) Figure 8. Global Linagliptin Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. Original Drug Product Image Figure 10. Generic Drug Product Image Figure 11. Hospital and Clinic Product Image Figure 12. Retail Pharmacies Product Image Figure 13. Other Product Image Figure 14. Global Linagliptin Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Linagliptin Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Linagliptin Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Linagliptin Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Linagliptin Tablets Sales by Region in 2025 Figure 20. Global Linagliptin Tablets Revenue by Region in 2025 Figure 21. North America Linagliptin Tablets Market Size by Country in 2025 Figure 22. North America Linagliptin Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Linagliptin Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Linagliptin Tablets Market Size by Country in 2025 Figure 28. Europe Linagliptin Tablets Sales Market Share by Country (2021-2032) Figure 29. Europe Linagliptin Tablets Revenue Market Share by Country (2021-2032) Figure 30. Germany Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Linagliptin Tablets Market Size by Country in 2025 Figure 41. Asia Pacific Linagliptin Tablets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Linagliptin Tablets Revenue Market Share by Country (2021-2032) Figure 43. China Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Linagliptin Tablets Market Size by Country in 2025 Figure 52. South America Linagliptin Tablets Sales Market Share by Country (2021-2032) Figure 53. South America Linagliptin Tablets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Linagliptin Tablets Market Size by Country in 2025 Figure 58. Middle East and Africa Linagliptin Tablets Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Linagliptin Tablets Revenue Market Share by Country (2021-2032) Figure 60. Egypt Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Linagliptin Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Linagliptin Tablets Sales Market Share by Type (2021-2032) Figure 66. Global Linagliptin Tablets Revenue Market Share by Type (2021-2032) Figure 67. Global Linagliptin Tablets Price (US$/Unit) by Type (2021-2032) Figure 68. Global Linagliptin Tablets Sales Market Share by Application (2021-2032) Figure 69. Global Linagliptin Tablets Revenue Market Share by Application (2021-2032) Figure 70. Global Linagliptin Tablets Price (US$/Unit) by Application (2021-2032) Figure 71. Linagliptin Tablets Value Chain Figure 72. Linagliptin Tablets Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Linagliptin Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Alkem
  • Boehringer Ingelheim
  • Cipla
  • Eli Lilly
  • Kyongbo Pharmaceutical
  • Lupin
  • Mankind Pharma
  • Myungmoon Pharm
  • Natco Pharma
  • Torrent Pharmaceuticals
  • Withus Pharmaceutical
  • Zydus
  • Chengdu Brilliant Pharmaceutical
  • HEC Pharm
  • Hangzhou Minsheng Pharmaceutical
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Yangtze River Pharmaceutical
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Linagliptin Tablets Market Size (2021-2032)
  4. 2.2.2 Global Linagliptin Tablets Sales (2021-2032)
  5. 2.2.3 Global Linagliptin Tablets Market Average Price (2021-2032)
  6. 2.3 Linagliptin Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Original Drug
  9. 2.3.3 Generic Drug
  10. 2.4 Linagliptin Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital and Clinic
  13. 2.4.3 Retail Pharmacies
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Linagliptin Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Linagliptin Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Linagliptin Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Linagliptin Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Linagliptin Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Linagliptin Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Linagliptin Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Linagliptin Tablets, Established Date
  9. 3.9 Global Linagliptin Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Alkem
  2. 4.1.1 Alkem Company Information
  3. 4.1.2 Alkem Business Overview
  4. 4.1.3 Alkem Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Alkem Linagliptin Tablets Product Portfolio
  6. 4.1.5 Alkem Recent Developments
  7. 4.2 Boehringer Ingelheim
  8. 4.2.1 Boehringer Ingelheim Company Information
  9. 4.2.2 Boehringer Ingelheim Business Overview
  10. 4.2.3 Boehringer Ingelheim Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boehringer Ingelheim Linagliptin Tablets Product Portfolio
  12. 4.2.5 Boehringer Ingelheim Recent Developments
  13. 4.3 Cipla
  14. 4.3.1 Cipla Company Information
  15. 4.3.2 Cipla Business Overview
  16. 4.3.3 Cipla Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Cipla Linagliptin Tablets Product Portfolio
  18. 4.3.5 Cipla Recent Developments
  19. 4.4 Eli Lilly
  20. 4.4.1 Eli Lilly Company Information
  21. 4.4.2 Eli Lilly Business Overview
  22. 4.4.3 Eli Lilly Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Eli Lilly Linagliptin Tablets Product Portfolio
  24. 4.4.5 Eli Lilly Recent Developments
  25. 4.5 Kyongbo Pharmaceutical
  26. 4.5.1 Kyongbo Pharmaceutical Company Information
  27. 4.5.2 Kyongbo Pharmaceutical Business Overview
  28. 4.5.3 Kyongbo Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Kyongbo Pharmaceutical Linagliptin Tablets Product Portfolio
  30. 4.5.5 Kyongbo Pharmaceutical Recent Developments
  31. 4.6 Lupin
  32. 4.6.1 Lupin Company Information
  33. 4.6.2 Lupin Business Overview
  34. 4.6.3 Lupin Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lupin Linagliptin Tablets Product Portfolio
  36. 4.6.5 Lupin Recent Developments
  37. 4.7 Mankind Pharma
  38. 4.7.1 Mankind Pharma Company Information
  39. 4.7.2 Mankind Pharma Business Overview
  40. 4.7.3 Mankind Pharma Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mankind Pharma Linagliptin Tablets Product Portfolio
  42. 4.7.5 Mankind Pharma Recent Developments
  43. 4.8 Myungmoon Pharm
  44. 4.8.1 Myungmoon Pharm Company Information
  45. 4.8.2 Myungmoon Pharm Business Overview
  46. 4.8.3 Myungmoon Pharm Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Myungmoon Pharm Linagliptin Tablets Product Portfolio
  48. 4.8.5 Myungmoon Pharm Recent Developments
  49. 4.9 Natco Pharma
  50. 4.9.1 Natco Pharma Company Information
  51. 4.9.2 Natco Pharma Business Overview
  52. 4.9.3 Natco Pharma Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Natco Pharma Linagliptin Tablets Product Portfolio
  54. 4.9.5 Natco Pharma Recent Developments
  55. 4.10 Torrent Pharmaceuticals
  56. 4.10.1 Torrent Pharmaceuticals Company Information
  57. 4.10.2 Torrent Pharmaceuticals Business Overview
  58. 4.10.3 Torrent Pharmaceuticals Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Torrent Pharmaceuticals Linagliptin Tablets Product Portfolio
  60. 4.10.5 Torrent Pharmaceuticals Recent Developments
  61. 4.11 Withus Pharmaceutical
  62. 4.11.1 Withus Pharmaceutical Company Information
  63. 4.11.2 Withus Pharmaceutical Business Overview
  64. 4.11.3 Withus Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Withus Pharmaceutical Linagliptin Tablets Product Portfolio
  66. 4.11.5 Withus Pharmaceutical Recent Developments
  67. 4.12 Zydus
  68. 4.12.1 Zydus Company Information
  69. 4.12.2 Zydus Business Overview
  70. 4.12.3 Zydus Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Zydus Linagliptin Tablets Product Portfolio
  72. 4.12.5 Zydus Recent Developments
  73. 4.13 Chengdu Brilliant Pharmaceutical
  74. 4.13.1 Chengdu Brilliant Pharmaceutical Company Information
  75. 4.13.2 Chengdu Brilliant Pharmaceutical Business Overview
  76. 4.13.3 Chengdu Brilliant Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Chengdu Brilliant Pharmaceutical Linagliptin Tablets Product Portfolio
  78. 4.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
  79. 4.14 HEC Pharm
  80. 4.14.1 HEC Pharm Company Information
  81. 4.14.2 HEC Pharm Business Overview
  82. 4.14.3 HEC Pharm Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 HEC Pharm Linagliptin Tablets Product Portfolio
  84. 4.14.5 HEC Pharm Recent Developments
  85. 4.15 Hangzhou Minsheng Pharmaceutical
  86. 4.15.1 Hangzhou Minsheng Pharmaceutical Company Information
  87. 4.15.2 Hangzhou Minsheng Pharmaceutical Business Overview
  88. 4.15.3 Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Product Portfolio
  90. 4.15.5 Hangzhou Minsheng Pharmaceutical Recent Developments
  91. 4.16 Kelun Pharmaceutical
  92. 4.16.1 Kelun Pharmaceutical Company Information
  93. 4.16.2 Kelun Pharmaceutical Business Overview
  94. 4.16.3 Kelun Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Kelun Pharmaceutical Linagliptin Tablets Product Portfolio
  96. 4.16.5 Kelun Pharmaceutical Recent Developments
  97. 4.17 Qilu Pharmaceutical
  98. 4.17.1 Qilu Pharmaceutical Company Information
  99. 4.17.2 Qilu Pharmaceutical Business Overview
  100. 4.17.3 Qilu Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Qilu Pharmaceutical Linagliptin Tablets Product Portfolio
  102. 4.17.5 Qilu Pharmaceutical Recent Developments
  103. 4.18 CSPC Ouyi Pharmaceutical
  104. 4.18.1 CSPC Ouyi Pharmaceutical Company Information
  105. 4.18.2 CSPC Ouyi Pharmaceutical Business Overview
  106. 4.18.3 CSPC Ouyi Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CSPC Ouyi Pharmaceutical Linagliptin Tablets Product Portfolio
  108. 4.18.5 CSPC Ouyi Pharmaceutical Recent Developments
  109. 4.19 Yangtze River Pharmaceutical
  110. 4.19.1 Yangtze River Pharmaceutical Company Information
  111. 4.19.2 Yangtze River Pharmaceutical Business Overview
  112. 4.19.3 Yangtze River Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Yangtze River Pharmaceutical Linagliptin Tablets Product Portfolio
  114. 4.19.5 Yangtze River Pharmaceutical Recent Developments
  115. 4.20 Zhejiang Huahai Pharmaceutical
  116. 4.20.1 Zhejiang Huahai Pharmaceutical Company Information
  117. 4.20.2 Zhejiang Huahai Pharmaceutical Business Overview
  118. 4.20.3 Zhejiang Huahai Pharmaceutical Linagliptin Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Zhejiang Huahai Pharmaceutical Linagliptin Tablets Product Portfolio
  120. 4.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
5 Global Linagliptin Tablets Market Scenario by Region
  1. 5.1 Global Linagliptin Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Linagliptin Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Linagliptin Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Linagliptin Tablets Sales by Region: 2027-2032
  5. 5.3 Global Linagliptin Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Linagliptin Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Linagliptin Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Linagliptin Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Linagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Linagliptin Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Linagliptin Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Linagliptin Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Linagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Linagliptin Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Linagliptin Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Linagliptin Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Linagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Linagliptin Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Linagliptin Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Linagliptin Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Linagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Linagliptin Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Linagliptin Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Linagliptin Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Linagliptin Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Linagliptin Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Linagliptin Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Linagliptin Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Linagliptin Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Linagliptin Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Linagliptin Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Linagliptin Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Linagliptin Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Linagliptin Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Linagliptin Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Linagliptin Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Linagliptin Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Linagliptin Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Linagliptin Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Linagliptin Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Linagliptin Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Linagliptin Tablets Value Chain Analysis
  2. 8.1.1 Linagliptin Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Linagliptin Tablets Production Mode & Process
  5. 8.2 Linagliptin Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Linagliptin Tablets Distributors
  8. 8.2.3 Linagliptin Tablets Customers
9 Global Linagliptin Tablets Analyzing Market Dynamics
  1. 9.1 Linagliptin Tablets Industry Trends
  2. 9.2 Linagliptin Tablets Industry Drivers
  3. 9.3 Linagliptin Tablets Industry Opportunities and Challenges
  4. 9.4 Linagliptin Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst